4/A//SEC Filing
Henderson Molly 4/A
Accession 0001209191-23-043162
CIK 0001783183other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 8:30 PM ET
Size
5.6 KB
Accession
0001209191-23-043162
Insider Transaction Report
Form 4/AAmended
Henderson Molly
CFO and CBO
Transactions
- Award
Common Stock
2023-07-14+25,000→ 95,180 total
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") granted on July 14, 2023. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of July 14, 2023, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]This amendment is being filed to correct the transaction price included in the Form 4 filed on behalf of the Reporting Person on July 17, 2023.
- [F3]Includes 1,674 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2023.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001363812
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 8:30 PM ET
- Size
- 5.6 KB